Skip to main content
. 2023 Nov 11;23:270. doi: 10.1186/s12935-023-03108-0

Table 1.

Patient characteristics

Patient ID Age (years) Serum PSA
(ng/ml)
Gleason score Tumor stage (TNM)
P1 67 53.7 9 T3bN1M0
P2 56 183.8 9 T3bN1M1
P3 63 27.3 8 T3bN1M0
P4 52 58 8 T3bN1M0
P5 74 896 9 T3bN1M1
P6 58 239.7 9 T3bN1M0
P7 81 69.1 8 T3bN1M1
P8 53 104 9 T3bN1M1
P9 66 38.8 8 T3bN1M0
P10 73 127.4 8 T3bN1M1

PSA prostate specific antigen, TNM tumor-node-metastasis